Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

Elevance Health’s Executive VP Charles Kendrick sold $1.4M worth of stock, reducing his stake by 40%. While insider sales can ...

Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

Elevance Health jumped 3.1% in the last session, extending its six-day rally. The surge was fueled by investor optimism, a ...

Elevance Health ELV -2.57% + Free Alerts has outperformed the market over the past 15 years by 2.24% on an annualized basis producing an average annual return of 13.22%. Currently, Elevance Health has ...

Shares of Elevance Health Inc. ELV shed 2.61% to $411.04 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 ...

Encore Healthcare has integrated its Nexus program with React Health, Mōvair and Philips cloud-based ventilator management platforms.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In the first episode of our series on the psychology of disappointment, Two Guys on Your Head, Art Markman, Bob Duke, and Rebecca McInroy talk about the role of expectations. The post ...

The Center for Mental Health and Addiction Policy (CMAP) is thrilled to announce its 2025 Nexus Series, Advancing Mental Health & Addiction Policy Solutions in 2025. This three-part event series will ...